SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
SEC Accession No. 0000909661-08-000032
Filing Date
2008-01-30
Accepted
2008-01-30 17:01:23
Documents
1
Group Members
ANDREW J. M. SPOKESASHISH H. PANTCHUN R. DINGDEREK C. SCHRIERDOUGLAS M. MACMAHONFARALLON CAPITAL INSTITUTIONAL PARTNERS II, L.P.FARALLON CAPITAL INSTITUTIONAL PARTNERS III, L.P.FARALLON CAPITAL INSTITUTIONAL PARTNERS, L.P.FARALLON CAPITAL OFFSHORE INVESTO

Document Format Files

Seq Description Document Type Size
1 medicinesco13ga1.htm SC 13G/A 574096
  Complete submission text file 0000909661-08-000032.txt   576888
Mailing Address ONE MARITIME PLAZA SUITE 2100 SAN FRANCISCO CA 94111
Business Address ONE MARITIME PLAZA SUITE 2100 SAN FRANCISCO CA 94111 (415)421-2132
FARALLON CAPITAL MANAGEMENT LLC (Filed by) CIK: 0000909661 (see all company filings)

IRS No.: 943240279
Type: SC 13G/A

Mailing Address
Business Address 8 CAMPUS DRIVE PARSIPPANY NJ 07054 973-656-1616
MEDICINES CO /DE (Subject) CIK: 0001113481 (see all company filings)

IRS No.: 043324394 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-60201 | Film No.: 08561738
SIC: 2834 Pharmaceutical Preparations